CRE INTELLIGENCE

RESEARCH

Part 2: The Life Science Capital Conundrum

While Part 1 focused on market dynamics, Part 2 delves into the crucial financial and infrastructurequestions: Who controls the assets, who holds the debt, and what is the true cost of bringing specializedlife sciences space online?

Read More

Part 1: The Dynamic Lab Market Supply, Demand, and the “Flight to Quality” in Life Sciences CRE

The U.S. life sciences real estate sector is undergoing a profoundtransformation. The market is characterized by a fundamental split: oversupplyin traditional R&D space coupled with soaring, policy-driven demand forspecialized Biomanufacturing facilities. The convergence of falling demand (due to the VC Reset) and surging speculative supplyhas created this imbalance, forcing a sharp re-evaluation of assets across […]

Read More

U.S. Office Market: Capital Markets and the New Playbook for Office CRE

The single greatest financial challenge for the office market is the looming “debt cliff.” As shown in thechart below, a significant volume of office loans are set to mature from 2025 to 2027. This represents aperfect storm for many owners, as much of this debt was originated in a low-interest-rate environment. When borrowers attempt to […]

Read More

The New Era of Hybrid Work and the ‘Flight to Experience’

The New Era of Hybrid Work and the ‘Flight to Experience’ The evolution of the U.S. office market is not solely a supply-side story. On the demandside, hybrid work has firmly established itself as the “new normal,” fundamentally changing how companies view and use office space. This shift has given rise to a new tenant […]

Read More